Cadrenal Therapeutics downsizes IPO, looks to raise $7 million

[ad_1] There are an increasing number of pharmaceutical companies taking the IPO route to increase their research and development activities – this trend continues in 2023. There are many biotech companies looking to go public this year, and Cadrenal Therapeutics,…








